Van ECK Associates Corp Has $316.24 Million Stake in The Clorox Company $CLX

Van ECK Associates Corp lifted its position in The Clorox Company (NYSE:CLX) by 15.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,136,405 shares of the company’s stock after purchasing an additional 426,433 shares during the quarter. Van ECK Associates Corp’s holdings in Clorox were worth $316,244,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Wilkins Investment Counsel Inc. raised its stake in Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Clorox by 27.0% during the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after acquiring an additional 197,330 shares in the last quarter. Morningstar Investment Management LLC raised its stake in Clorox by 131.8% during the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares in the last quarter. Swiss Life Asset Management Ltd raised its stake in Clorox by 221.4% during the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after acquiring an additional 59,533 shares in the last quarter. Finally, Birch Hill Investment Advisors LLC acquired a new position in Clorox during the fourth quarter worth $22,103,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Morgan Stanley dropped their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Wells Fargo & Company dropped their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. Evercore reiterated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, TD Cowen increased their price objective on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $103.40.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of CLX stock opened at $96.74 on Friday. The stock’s fifty day moving average is $96.43 and its 200-day moving average is $105.20. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market capitalization of $11.70 billion, a PE ratio of 15.70, a PEG ratio of 0.51 and a beta of 0.56. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.